Professor of Surgery, Wayne State University
General Surgery
Dr. Marwan S. Abouljoud, MD
|
|
Give Review
Doctor Marwan S. Abouljoud, MD works in the field of General Surgery. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer" and "Fellow (FACS)". Marwan S. Abouljoud has written publications. He has 77 publications published with PubMed. The lastest paper is: 'Combination antifungal therapy for invasive aspergillosis infection in liver transplant recipients: report of two patients.' He is registered with Medicare.
Publications
- Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation.
- Health literacy in patients referred for transplant: do patients have the capacity to understand?
- Beyond survival: how well do transplanted livers work? A preliminary comparison of standard-risk, high-risk, and living donor recipients.
- Liver Transplantation for Patient With Pretransplant Undetectable Hepatitis C RNA: Can Eradication of Virus Guarantee Superior Outcome?
- Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation.
- Renal allograft outcome in recipients of positive-crossmatch combined liver-kidney transplantation.
- Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
- Emergent non-conventional meso-systemic shunt for diffuse porto-mesenteric thrombosis: Spare the chance for liver/multivisceral transplantation.
- Thrombolysis of Portal Vein Thrombosis After Splenectomy Post Liver Transplant.
- Transplant programs, centers, and institutes: what does it all mean?
- Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
- Transplant organizational structures: viewpoints from established centers.
- Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome.
- Mini-incision right hepatic lobectomy with and without laparoscopic assistance for living donor hepatectomy.
- Adult portal hypertension secondary to posttraumatic extrahepatic portal vein thrombosis treated with Rex shunt.
- Resection of giant liver adenoma in a 17-year-old adolescent boy using venovenous bypass, total hepatic vascular isolation, and in situ cooling.
- Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation.
- Impact of aberrant arterial anatomy and location of anastomosis on technical outcomes after liver transplantation.
- Cavernous hemangioma presenting as Budd-Chiari syndrome.
- Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
- Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes.
- The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
- Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease.
- The influence of alcohol abuse history on the differential, longitudinal patterns of mental and physical quality of life following liver transplantation.
- Survival after liver transplantation in patients who develop renal insufficiency.
- New application of the bipolar vapor plasma coagulation system for laparoscopic major liver resections.
- Left renal vein ligation: a technique to mitigate low portal flow from splenic vein siphon during liver transplantation.
- Neuropsychological changes in a large sample of liver transplant candidates.
- Hypercoagulability risks among adult living liver donors.
- Sonographic differences in venous return between piggyback versus caval interposition in adult liver transplantations.
- Influence of hepatitis C on renal function after liver transplantation.
- Renal disease burden following liver transplantation.
- One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.
- Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
- Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
- A national study of burnout among American transplant surgeons.
- Living donor and split-liver transplantation: an overview.
- Peritoneal dialysis catheter obstruction by a fallopian tube: a case report.
- Use of polypropylene mesh to stabilize the "floating humerus" after total scapulectomy.
- Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
- Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy.
- A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transpla...
- Quality of life improvements at one, two, and five years after liver transplantation.
- Use of anti-hepatitis C virus seropositive organs in liver transplantation.
- Baylor update: outcome analysis in liver transplantation.
- Obstruction of PD catheters by fallopian tubes.
- Arterial injuries of the thoracic outlet: a ten-year experience.
- Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
- Separate risk factors for the development of transplant glomerulopathy vs chronic tubulointerstitial rejection.
- Cost-effective management of acute rejection in liver transplant recipients: a managed care perspective.
- Combination antifungal therapy for invasive aspergillosis infection in liver transplant recipients: report of two patients.
- Cost-utility analysis of living-donor kidney transplantation followed by pancreas transplantation versus simultaneous pancreas-kidney transplantation.
- Quantitation of hepatitis C virus RNA in liver tissue of allografts: correlation with histologic features and liver function tests.
- Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mo...
- Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
- Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
- Short-term results of radiofrequency ablation in liver tumors.
- High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome.
- Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf.
- The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
- Successful strategy for reducing biliary complications after liver transplantation.
- Recurrent disease after liver transplantation.
- Neoral rescue therapy in transplant patients with intolerance to tacrolimus.
- Duodenal enteroglucagonoma revealed by differential comparison of serum and tissue glucagon reactivity with Siemens'' Double Glucagon Antibody and DakoCytomation''s Po...
- Experience with recipient splenic artery inflow in adult liver transplantation: a case series.
- Hepatitis C virus-specific T-cell gamma interferon and proliferative responses are more common in perihepatic lymph nodes than in peripheral blood or liver.
- Risk of venous thrombosis in patients with hepatic malignancies undergoing surgical resection.
- Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
- Renal insufficiency after liver transplantation in the MELD era compared to the pre-MELD era.
- Aberrant right hepatic duct draining into the cystic duct: clinical outcomes and management.
- Outcome with surgical repair of extrahepatic portal vein aneurysms.
- Increasing trend in infection-related death-censored graft failure in renal transplantation.
- Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
- The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors.
- Rapid progression of native renal artery fibromuscular dysplasia following kidney donation.
- Successful internalization of a chronic biliary cutaneous fistula after liver transplantation: deepithelializing the fistula tract.
Schools
American University of Beirut Faculty of Medicine
Henry Ford Hospital
Procedures Preformed
- Ablation
- Bile Duct Surgery
- Embolization
- Embolization of Tumor
- View All
Doctors Specialties
- Surgical Oncology
- Transplant Surgery
- General Surgery
Accepted Insurances
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Priority PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
Henry Ford Hospital - Wayne State University -
University of Michigan Hospitals and Health Centers -
American University of Beirut Faculty of Medicine
Hospital
-
Henry Ford Hospital
Drug Facts
| NPI NUMBER | 1316000896 | |
| NPPES Provider LastName | ABOULJOUD | |
| NPPES Provider FirstName | MARWAN | |
| NPPES Provider ZIPCode | 48202 | |
| NPPES Provider State | MI | |
| Specialty Description | General Surgery | |
| Total Claim Count | 137.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316000896 |
| Last Name Of The Provider | ABOULJOUD |
| First Name Of The Provider | MARWAN |
| View All |
Similar Doctors
|
Dr. Pamela D. Johnson, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Atsushi Yoshida, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David A. Bruno, MD |
|
Dr. S David Nathanson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lauren Malinzak, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David S. Kwon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian R. Lace, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chandramani N. Mohan, MD |
|
|
Dr. Farah Hanif Ali Mohammad, MD |
|
|
Dr. Roy J. Golden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew R. Isaacson, MD |
|
|
Dr. Vrishali P. Patil, MD
This Doctor is OpenDoctor Recommended.
|